NICE Provisional Approval for Digital Therapies to Treat Tourette Syndrome

The National Institute for Health and Care Excellence (NICE) has provisionally approved two innovative digital therapies for Tourette syndrome, marking a significant advancement in treatment options. The approved technologies, Online Remote Behavioural Intervention for Tics (ORBIT) and Nepulse, aim to enhance the quality of life for those affected by chronic tic disorders. This landmark decision could transform care accessibility, particularly for individuals in rural areas, as NICE emphasizes the need for equitable treatment solutions.